The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease
Abstract
Resistance to insulin-mediated glucose disposal has been postulated to predispose individuals to a cluster of associated abnormalities (Syndrome X) known to increase risk of cardiovascular disease (CVD). Although several abnormalities subsumed under the rubric of Syndrome X have been shown to predict CVD, there has been no prospective study evaluating the power of insulin resistance, the putative fundamental defect in the syndrome, in this context. Therefore, this study was initiated to evaluate the hypothesis that resistance to insulin-mediated glucose disposal would predict the development of CVD in healthy volunteers. To accomplish this goal, 147 normal, healthy, nonobese, volunteers were evaluated [4.7 +/- 0.1 yr (mean +/- SEM)] after baseline measurements of steady state plasma glucose concentration (an estimate of insulin-mediated glucose disposal), as well as other CVD risk factors. Clinical end points developed in 13 subjects during the follow-up period; hypertension in 5, coronary artery disease in 4, cerebrovascular accident in 3, and peripheral vascular disease in 1. There was a significant univariate relationship between SSPG and CVD (P < 0.002), with the majority of the events taking place in the tertile of subjects with the highest SSPG concentration, i.e. the greatest degree of insulin resistance. In contrast, no CVD events were observed in the tertile with the lowest SSPG concentrations; the most insulin sensitive. SSPG was also related significantly to diastolic blood pressure, triglyceride, and low-density lipoprotein and high-density lipoprotein cholesterol concentrations, and the glucose and insulin responses to oral glucose. All of these relationships were independent of age, gender, body mass index, estimates of physical activity, and smoking history. When SSPG was paired with each of the other variables in a series of multiple regression models, only SSPG, or insulin response, were independent predictors of CVD events. In conclusion, approximately one of every five healthy, nonobese subjects in the most insulin-resistant tertile, followed for approximately 5 yr, had a serious clinical event. These data highlight the importance of insulin resistance as a predictor of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Self-citationImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1992) · Medical Science Symposia Series · doi:10.1007/978-94-011-2700-4_10 · Cited by 865
Pyörälä, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.131 · Cited by 768
Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., & Rosselin, G. (1980) · Diabetologia · doi:10.1007/bf00275270 · Cited by 747
A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption
Kadish, A. H., Litle, R. L., & Sternberg, J. C. (1968) · Clinical Chemistry · doi:10.1093/clinchem/14.2.116 · Cited by 740
Welborn, T. A., & Wearne, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.154 · Cited by 735
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Cited by
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1904 · Cited by 3,651
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
“Indeed, SSPG has positive predictive power for cardiovascular disease events and onset of type 2 diabetes (36, 103).”
BackgroundLipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Self-citationGall, W. E., Beebe, K., Lawton, K. A., Adam, K.-P., Mitchell, M. W., Nakhle, P. J., Ryals, J. A., Milburn, M. V., Nannipieri, M., Camastra, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010883 · Cited by 698
McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658
Bonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604
Insulin resistance as a predictor of age-related diseases
Facchini, F. S., Hua, N., Abbasi, F., & Reaven, G. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7763 · Cited by 594
Self-citationRelationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581
Relationship between obesity, insulin resistance, and coronary heart disease risk
Abbasi, F., Brown, B. W., Lamendola, C., McLaughlin, T., & Reaven, G. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02051-x · Cited by 573
The metabolic syndrome: is this diagnosis necessary?1,2
Reaven, G. M. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1237 · Cited by 524
THE INSULIN RESISTANCE SYNDROME: Definition and Dietary Approaches to Treatment
Reaven, G. M. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132155 · Cited by 516
“Prospective studies from our research group have indicated that the upper one-third of an apparently healthy population is sufficiently insulin resistant to develop the adverse clinical syndromes of the IRS, whereas those in the lower one-third of the population are at much less risk (13, 62).”
BackgroundSelf-citationReaven, G. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.002 · Cited by 507
Metabolic syndrome: Definition, pathophysiology, and mechanisms
Miranda, P. J., DeFronzo, R. A., Califf, R. M., & Guyton, J. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.013 · Cited by 479
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427
Magge, S. N., Goodman, E., Armstrong, S. C., COMMITTEE ON NUTRITION, ENDOCRINOLOGY, S. O., OBESITY, S. O., Daniels, S., Corkins, M., de Ferranti, S., Golden, N. H., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1603 · Cited by 401
Insulin Resistance: the Link Between Obesity and Cardiovascular Disease
Reaven, G. M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.002 · Cited by 395
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1876-2 · Cited by 376
McLaughlin, T., Liu, L.-F., Lamendola, C., Shen, L., Morton, J., Rivas, H., Winer, D., Tolentino, L., Choi, O., Zhang, H., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304636 · Cited by 364
Shin, J., Lee, J., Lim, S., Ha, H., Kwon, H., Park, Y., Lee, W., Kang, M., Yim, H., Yoon, K., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12075 · Cited by 350
Pyörälä, M., Miettinen, H., Halonen, P., Laakso, M., & Pyörälä, K. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.538 · Cited by 349
Obesity, Insulin Resistance, and Cardiovascular Disease
Reaven, G. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.207 · Cited by 348
Du, X., Edelstein, D., Obici, S., Higham, N., Zou, & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 347
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M. (2007) · Diabetes Care · doi:10.2337/dc06-0919 · Cited by 343
Sabuncu, T., Vural, H., Harma, M., & Harma, M. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00245-4 · Cited by 323
Insulin resistance in type 2 diabetes: role of fatty acids
Arner, P. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.254 · Cited by 323
Carrel, A. L., Clark, R. R., Peterson, S. E., Nemeth, B. A., Sullivan, J., & Allen, D. B. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.10.963 · Cited by 318
Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1195 · Cited by 312
Self-citationInsulin resistance is a cardiovascular risk factor in humans
Adeva-Andany, M. M., Martínez-Rodríguez, J., González-Lucán, M., Fernández-Fernández, C., & Castro-Quintela, E. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.023 · Cited by 313
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3252 · Cited by 307
McLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268
Self-citationGoodman, E., Daniels, S. R., Morrison, J. A., Huang, B., & Dolan, L. M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.04.059 · Cited by 264
Elting, M. W., Korsen, T. J. M., Bezemer, P. D., & Schoemaker, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.556 · Cited by 254
Insulin resistance and coronary heart disease in nondiabetic individuals
Reaven, G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241885 · Cited by 227
The metabolic syndrome: time to get off the merry-go-round?: Review: The metabolic syndrome
Reaven, G. M. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02325.x · Cited by 214
Self-citationIdentification and validation of N-acetyltransferase 2 as an insulin sensitivity gene
Knowles, J. W., Xie, W., Zhang, Z., Chennemsetty, I., Assimes, T. L., Paananen, J., Hansson, O., Pankow, J., Goodarzi, M. O., Carcamo-Orive, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74692 · Cited by 141
Self-citationReaven, G. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.017 · Cited by 135
Mirror, Mirror on the Wall: When the Postoperative Reflection Does Not Meet Patientsʼ Expectations
Rohrich, R. J. (2001) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-200108000-00035 · Cited by 130
Kim, J.-H., Cho, J. J., & Park, Y. S. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.3.264 · Cited by 126
Jones, R., Pabla, P., Mallinson, J., Nixon, A., Taylor, T., Bennett, A., & Tsintzas, K. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa192 · Cited by 115
“Although improvements in insulin sensitivity are likely more relevant to clinical populations at an increased susceptibility to metabolic disease(s), even in healthy individuals, insulin sensitivity is an independent predictor of future cardiovascular disease (42, 43).”
BackgroundStatins are associated with increased insulin resistance and secretion
Abbasi, F., Lamendola, C., Harris, C. S., Harris, V., Tsai, M.-S., Tripathi, P., Abbas, F., Reaven, G. M., Reaven, P. D., Snyder, M. P., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316159 · Cited by 98
Self-citationMcLaughlin, T., Carter, S., Lamendola, C., Abbasi, F., Yee, G., Schaaf, P., Basina, M., & Reaven, G. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.813 · Cited by 95
Self-citationCarlsson, M., Wessman, Y., Almgren, P., & Groop, L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1588 · Cited by 95
Simonson, G. D., & Kendall, D. M. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200512000-00002 · Cited by 38
Tuan, C.-Y., Abbasi, F., Lamendola, C., McLaughlin, T., & Reaven, G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00735-5 · Cited by 34
Self-citationKim, H.-S., Abbasi, F., Lamendola, C., McLaughlin, T., & Reaven, G. M. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.592 · Cited by 33
Self-citationRisk for obstructive sleep apnea in obese, nondiabetic adults varies with insulin resistance status
Liu, A., Kushida, C. A., & Reaven, G. M. (2013) · Sleep and Breathing · doi:10.1007/s11325-012-0696-0 · Cited by 8
“Subsequent prospective studies have demonstrated significant increases in the development of adverse clinical outcomes, including cardiovascular disease, in the most insulin-resistant third of a population without known disease at baseline [16, 17].”
BackgroundSelf-citation
Metadata
- Authors
- Yip, J.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-08-01
- Volume
- 83
- Issue
- 8
- Pages
- 2773-2776
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2156536882
- Cited by
- 360
- References
- 25
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.